Publications
Publications 12426 - 12450 de 33557
| Titre | DOI |
|---|---|
|
Fifteen years of research on oral-facial-digital syndromes: from 1 to 16 causal genes A.L. Bruel; B. Franco; Y. Duffourd; J. Thevenon; L. Jego; E. Lopez; J.F. Deleuze; D. Doummar; R.H. Giles; C.A. Johnson; M.A. Huynen; V. Chevrier; L. Burglen; M. Morleo; I. Desguerres; G. Pierquin; B. Doray; B. Gilbert-Dussardier; B. Reversade; E. Steichen-Gersdorf; C. Baumann; I. Panigrahi; A. Fargeot-Espaliat; A. Dieux; A. David; A. Goldenberg; E. Bongers; D. Gaillard; J. Argente; B. Aral; N. Gigot; J. St-Onge; D. Birnbaum; S.R. Phadke; V. Cormier-Daire; T. Eguether; G.J. Pazour; V. Herranz-Perez; J.S. Goldstein; L. Pasquier; P. Loget; S. Saunier; A. Megarbane; O. Rosnet; M.R. Leroux; J.B. Wallingford; O.E. Blacque; M.V. Nachury; T. Attie-Bitach; J.B. Riviere; L. Faivre; C. Thauvin-Robinet 2017 |
10.1136/jmedgenet-2016-104436 |
|
Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. P. Poortmans; S. Collette; H. Struikmans; K. De Winter; E. Van Limbergen; C. Kirkove; V. Budach; K. Peignaux-Casasnovas; E. Vonk; D.D. Vandenbongard; S. Rivera; D. Zips; G. van Tienhoven; M. Guckenberger; R. Abdah-Bortnyak; A. Fourquet; H.G.M. Bartelink 2018 |
10.1200/JCO.2018.36.15_suppl.504 |
|
Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme N. Aissaoui; E. Puymirat; Y. Juilliere; P. Jourdain; D. Blanchard; F. Schiele; P. Gueret; B. Popovic; J. Ferrieres; T. Simon; N. Danchin 2016 |
10.1002/ejhf.585 |
|
Fight or Flight? Understanding Different Stakeholder Responses to Conservation Conflicts I.D. Hodgson; A. Fischer; S.M. Redpath; J.C. Young Submitted |
10.1080/08941920.2022.2048933 |
|
FIGHT: A randomized, double-blind, placebo-controlled, phase II study of bemarituzumab (bema) combined with modified FOLFOX6 in 1L FGFR2b+advanced gastric/gastroesophageal junction adenocarcinoma (GC). D.V.T. Catenacci; Y.K. Kang; A. Saeed; K. Yamaguchi; S. Qin; K.W. Lee; I.H. Kim; S.Cheul Oh; J. Li; H.M. Turk; A.Carolina Teixeira; C. Borg; E. Hitre; A.Adrian Udrea; G.Gerardo Cardellino; R. Guardeno; S. Mitra; Y. Yang; P.C. Enzinger; Z.A. Wainberg 2021 |
10.1200/JCO.2021.39.15_suppl.4010 |
|
Fighting bacterial infections : the plant immune system is also very efficient! J. Claverie; L. Teyssier; D. Brule; M.C. Heloir; J.L. Connat; O. Lamotte; B. Poinssot 2016 |
10.1051/medsci/20163204008 |
|
FIGHTING MULTI-MARKET CARTELS: AN EXPERIMENTAL COMPARISON OF THE AMERICAN AND EUROPEAN LENIENCY PROGRAMS K. Brisset; F. Cochard; E.A. Lambert 2019 |
|
|
FIGHTING MULTI-MARKET CARTELS: AN EXPERIMENTAL COMPARISON OF THE AMERICAN AND EUROPEAN LENIENCY PROGRAMS K. Brisset; F. Cochard; E.A. Lambert 2019 |
|
|
Figures of witnesses: literary and fictional Mediations of the Tutsi genocide in Rwanda V. Brinker 2016 |
10.1080/17409292.2016.1144850 |
|
Filament-induced visible-to-mid-IR supercontinuum in a ZnSe crystal: Towards multi-octave supercontinuum absorption spectroscopy O. Mouawad; P. Bejot; F. Billard; P. Mathey; B. Kibler; F. Desevedavy; G. Gadret; J.C. Jules; O. Faucher; E. Smektala 2016 |
10.1016/j.optmat.2016.08.009 |
|
Filamentary deposition of laser energy in glasses with Bessel beams M. Lamperti; V. Jukna; O. Jedrkiewicz; P. Di Trapani; R. Stoian; T.E. Itina; C. Xie; F. Courvoisier; A. Couairon 2018 |
10.1063/1.5053085 |
|
Filamentation with nonlinear Bessel vortices V. Jukna; C. Milian; C. Xie; T. Itina; J. Dudley; F. Courvoisier; A. Couairon 2014 |
10.1364/OE.22.025410 |
|
Filamentation-induced spectral broadening and pulse shortening of infrared pulses in Tellurite glass P. Bejot; F. Billard; C. Peureux; T. Diard; J. Picot-Clemente; C. Strutynski; P. Mathey; O. Mouawad; O. Faucher; K. Nagasaka; Y. Ohishi; F. Smektala 2016 |
10.1016/j.optcom.2016.06.003 |
|
Filled with Smells G. Brand 2019 |
|
|
Filleting sharp edges of multi-partitioned volume finite element meshes R. Lou; J.P. Pernot; F. Giannini; P. Veron; B. Falcidieno 2015 |
10.1108/EC-03-2013-0074 |
|
Film programming: curating for cinemas, festivals, archives M.C. Hayes 2016 |
10.1080/01439685.2016.1164482 |
|
Films without images: a history of unrealized scenarios of `The human Condition' J. Loehr 2016 |
10.1093/fs/knw014 |
|
Final analysis of COMET-1: Cabozantinib (Cabo) versus prednisone (Pred) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) previously treated with docetaxel (D) and abiraterone (A) and/or enzalutamide (E). M.Raymond Smith; J.Sebastian De Bono; C.N. Sternberg; S. Le Moulec; S. Oudard; U. De Giorgi; M. Krainer; A.M. Bergman; W. Hoelzer; R. De Wit; M. Boegemann; F. Saad; G. Cruciani; A. Thiery-Vuillemin; S. Feyerabend; K. Miller; D.Albert Ramies; C. Hessel; A. Weitzman; K. Fizazi 2015 |
10.1200/jco.2015.33.7_suppl.139 |
|
Final Analysis of the ALFA 0701 Study S. Castaigne; C. Pautas; C. Terre; A. Renneville; C. Gardin; F. Suarez; D. Caillot; C. Berthon; P. Rousselot; C. Preudhomme; L. Morisset; K.Celli Lebras; S. Chevret; H. Dombret 2014 |
|
|
Final Analysis of the ALFA 0701 Study S. Castaigne; C. Pautas; C. Terre; A. Renneville; C. Gardin; F. Suarez; D. Caillot; C. Berthon; P. Rousselot; C. Preudhomme; L. Morisset; K.Celli Lebras; S. Chevret; H. Dombret 2014 |
|
|
Final Analysis of the RO-CHOP Phase Ib/II Study: Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL) J. Dupuis; F. Morschhauser; H. Ghesquieres; H. Tilly; O. Casasnovas; S. Amorim; V. Ribrag; B. Coiffier 2014 |
|
|
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer R. Bell; J. Brown; M. Parmar; M. Toi; T. Suter; G.G. Steger; X. Pivot; J. Mackey; C. Jackisch; R. Dent; P. Hall; N. Xu; L. Morales; L. Provencher; R. Hegg; L. Vanlemmens; A. Kirsch; A. Schneeweiss; N. Masuda; F. Overkamp; D. Cameron 2017 |
10.1093/annonc/mdw665 |
|
Final efficacy results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer R. Bell; J. Brown; M. Parmar; M. Toi; T. Suter; G. Steger; X. Pivot; J. Mackey; C. Jackisch; R. Dent; P. Hall; A. Mecke; L. Morales; L. Provencher; E. Staroslawska; R. Hegg; L. Vanlemmens; A. Kirsch; A. Schneeweiss; N. Masuda; F. Overkamp; D. Cameron 2015 |
10.1158/1538-7445.SABCS14-PD2-2 |
|
Final overall survival (OS) analysis of PROfound: Olaparib vs physician's choice of enzalutamide or abiraterone in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations J.S. de Bono; J. Mateo; K. Fizazi; F. Saad; N. Shore; S. Sandhu; K.N. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; G. Roubaud; M. Ozguroglu; J. Kang; J. Burgents; C. Gresty; C. Corcoran; C.A. Adelman; M. Hussain 2020 |
10.1016/j.annonc.2020.08.870 |
|
Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC). G. Baciarello; R. Delva; G. Gravis; Y. Tazi; C. Theodore; M. Gross-Goupil; E. Bompas; F. Joly; T. Lharidon; T.Nguyen Tan Hon; P. Barthelemy; S. Culine; J.Francois Berdah; M. Deblock; P. Beuzeboc; A. Flechon; C. Cheneau; G. Martineau; I. Borget; K. Fizazi 2019 |
10.1200/JCO.2019.37.15_suppl.5017 |